These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23116891)

  • 1. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: part 3, novel propellane derivatives with pentacyclic skeletons.
    Fujii H; Nakajima R; Akiyama J; Yamamoto N; Hirayama S; Nemoto T; Gouda H; Hirono S; Nagase H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7697-701. PubMed ID: 23116891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology: part 1.
    Yamamoto N; Fujii H; Nemoto T; Nakajima R; Momen S; Izumimoto N; Hasebe K; Mochizuki H; Nagase H
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4104-7. PubMed ID: 21641798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology. Part 2: Propellane derivatives with an amide side chain.
    Nagase H; Akiyama J; Nakajima R; Hirayama S; Nemoto T; Gouda H; Hirono S; Fujii H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2775-9. PubMed ID: 22460026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chain.
    Nakajima R; Yamamoto N; Hirayama S; Iwai T; Saitoh A; Nagumo Y; Fujii H; Nagase H
    Bioorg Med Chem; 2015 Oct; 23(19):6271-9. PubMed ID: 26346669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. Part 2: Synthesis of novel triplet drugs with the epoxymethano structure (capped homotriplet).
    Nagase H; Koyano K; Wada N; Hirayama S; Watanabe A; Nemoto T; Nakajima M; Nakao K; Mochizuki H; Fujii H
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6198-202. PubMed ID: 21889335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of quinolinopropellane derivatives with selective δ opioid receptor agonism.
    Nagase H; Nakajima R; Yamamoto N; Hirayama S; Iwai T; Nemoto T; Gouda H; Hirono S; Fujii H
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2851-4. PubMed ID: 24835200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology.
    Nagase H; Watanabe A; Nemoto T; Yamaotsu N; Hayashida K; Nakajima M; Hasebe K; Nakao K; Mochizuki H; Hirono S; Fujii H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):121-4. PubMed ID: 19962305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a novel universal opioid receptor agonist with the 1,3,5-trioxazatriquinane skeleton and its pharmacologies.
    Hirayama S; Wada N; Kuroda N; Iwai T; Yamaotsu N; Hirono S; Fujii H; Nagase H
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4895-8. PubMed ID: 25248680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel triplets with a 1,3,5-trioxazatriquinane skeleton and their pharmacologies for opioid receptors.
    Nagase H; Kutsumura N
    Arch Pharm (Weinheim); 2015 Jun; 348(6):375-89. PubMed ID: 25964204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton having a 7-amide side chain and their pharmacologies.
    Watanabe Y; Kitazawa S; Nemoto T; Hirayama S; Iwai T; Fujii H; Nagase H
    Bioorg Med Chem; 2013 Jun; 21(11):3032-50. PubMed ID: 23623711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and receptor affinity of novel conformationally restricted σ ligands based on the [4.3.3]propellane scaffold.
    Torres-Gómez H; Lehmkuhl K; Schepmann D; Wünsch B
    Eur J Med Chem; 2013; 70():78-87. PubMed ID: 24140950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 6,14-epoxymorphinan derivatives and their pharmacologies.
    Nemoto T; Yamamoto N; Watanabe A; Fujii H; Hasebe K; Nakajima M; Mochizuki H; Nagase H
    Bioorg Med Chem; 2011 Feb; 19(3):1205-21. PubMed ID: 21256034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationship of novel opioid κ receptor selective agonists: α-iminoamide derivatives with an azabicyclo[2.2.2]octene skeleton.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Iwai T; Gouda H; Hirono S; Nagasea H
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4980-3. PubMed ID: 25283554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential structure of opioid κ receptor agonist nalfurafine for binding to the κ receptor 3: synthesis of decahydro(iminoethano)phenanthrene derivatives with an oxygen functionality at the 3-position and their pharmacologies.
    Fujii H; Imaide S; Hirayama S; Nemoto T; Gouda H; Hirono S; Nagase H
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7711-4. PubMed ID: 23103094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric syntheses, opioid receptor affinities, and antinociceptive effects of 8-amino-5,9-methanobenzocyclooctenes, a new class of structural analogues of the morphine alkaloids.
    Schultz AG; Wang A; Alva C; Sebastian A; Glick SD; Deecher DC; Bidlack JM
    J Med Chem; 1996 May; 39(10):1956-66. PubMed ID: 8642554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons.
    Nagase H; Watanabe A; Nemoto T; Nakajima M; Hasebe K; Mochizuki H; Fujii H
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4023-6. PubMed ID: 21641219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonists.
    Chu GH; Gu M; Cassel JA; Belanger S; Stabley GJ; DeHaven RN; Conway-James N; Koblish M; Little PJ; DeHaven-Hudkins DL; Dolle RE
    Bioorg Med Chem Lett; 2006 Feb; 16(3):645-8. PubMed ID: 16263278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists.
    Bourgeois C; Werfel E; Galla F; Lehmkuhl K; Torres-Gómez H; Schepmann D; Kögel B; Christoph T; Straßburger W; Englberger W; Soeberdt M; Hüwel S; Galla HJ; Wünsch B
    J Med Chem; 2014 Aug; 57(15):6845-60. PubMed ID: 25062506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.